MELATONIN, PRO-INFLAMMATORY CYTOKINES AND PLACENTAL INSUFFICIENCY

Authors

  • A. M. Berbets Вищий державний навчальний заклад України «Буковинський державний медичний університет», Чернівці

DOI:

https://doi.org/10.11603/24116-4944.2018.2.8942

Keywords:

melatonin, placenta, cytokines, intrauterine fetal growth restriction

Abstract

The aim of the study – to establish the correlation between the placental insufficiency and pro-inflammatory part of the immune system by studying of the levels of melatonin and pro-inflammatory cytokines in pregnant women with placental insufficiency.

Materials and Methods. 46 pregnant women with placental insufficiency were examined. The placental insufficiency manifested as the intrauterine growth restriction syndrome (IUGR) of the II-III degree in pregnancy terms 30–36 weeks. Control group consisted of 20 women with uncomplicated pregnancy in the same term. The kit of reagents Melatonin ELISA, manufactured by IBL, Germany, was used for studying of the blood concentrations of melatonin. Pro-inflammatory cytokines, such as tumor necrotizing factor-α (TNF-α), interleukin-1-β (IL-1-β), interleukin-6 (IL-6) were determined in the blood using reagents manufactured by “Vektor-Best” (Ukraine).

Results and Discussion. We established that concentration of melatonin significantly decreases, if the pregnancy is complicated by intrauterine fetal growth restriction (study group – (126.87±14.87) pg/ml, control group – (231.25±21.56) pg/ml, p<0,001). The levels of pro-inflammatory cytokines in the study group were significantly higher, comparing with the control group (TNF-α: study group – (10.05±1.35) pg/ml, control group – (5.60±1.50) pg/ml, p<0.05; IL-1-β: study group – (14.67±2.13) pg/ml, control group – (3.96±0.92) pg/ml, p<0,001; IL-6: study group – (6.91±0.99) pg/ml, control group – (2.69±0.99) pg/ml, p<0.05).

Conclusions. The blood level of melatonin significantly decreases in case of placental insufficiency, manifested as intrauterine fetal growth restriction. The strengthening of the pro-inflammatory immunity, shown as the increasing of the levels of TNF-α, IL-1-β and IL-6, is also present in case of IUGR.

Author Biography

  • A. M. Berbets, Вищий державний навчальний заклад України «Буковинський державний медичний університет», Чернівці
     

References

Grishchenko, V.I. (1979). Rol epifiza v fiziologii i patologii zhenskoy polovoy sistemy [Role of a pineal gland in physiolo­gy and pathology of woman’s reproductive system]. Kharkiv: Vyshcha shkola [in Russian].

Shimada, M., Seki, H., Samejima, M., Hayase, M., & Shirai, F. (2016). Salivary melatonin levels and sleep-wake rhythms in pregnant women with hypertensive and glucose metabolic disorders: A prospective analysis. BioSci. Trends, 10 (1), 34-41. DOI: 10.5582/bst.2015.01123.

Soliman, A., Lacasse, A., Lanoix, D., Sagrillo-Fagundes, L., Boulard, V., & Vaillancourt, C. (2015). Placental melatonin system is present throughout pregnancy and regulates villous trophoblast differentiation. J. Pineal Res., 59 (1), 38-46. DOI: 10.1111/jpi.12236.

Takayama, H., Nakamura, Y., & Tamura, H. (2003). Pineal gland (melatonin) affects the parturition time but not luteal function and fetal growth, in pregnant rats. Endocr. J., 50 (1), 37-43. DOI: 10.1507/endocrj.50.37.

Teixeira, A.A., Simoes, M.J., Wanderley Teixeira, V., & Soares, J.Jr. (2004). Evaluation of the implantation in pinealectomized and/or submitted to the constant illumination rats. Int. J. Morphol., 22 (3), 189-194.

Richter, H.G., Hansell, J.A., Raut, Sh., & Giussani, D.A. (2009). Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J. Pineal Res., 46, 357-364. DOI: 10.1111/j.1600-079X.2009.00671.x.

Reiter, R.J., Dun Xian Tan, Korkmaz, A., & Rosales-Corral, S.A. (2013). Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology. Hum. Reprod. Update, 20 (2), 293-307. DOI: 10.1093/humupd/dmt054.

Marseglia, L., D’Angelo, G., Manti, S., Reiter, R.J., & Gitto, E. (2016). Potential utility of melatonin in preeclampsia, intrauterine fetal growth retardation, and perinatal asphyxia. Reprod. Sci., 23 (8), 970-977. DOI: 10.1177/1933719115612132.

Esroy, O.F., Özkan, N., & Özsoy, Z. (2016). Effects of melatonin on cytokine release and healing of colonic anastomoses in an experimental sepsis model. Ulus Travma Acil Cerrahi Derg., 22 (4), 315-321. DOI: 10.5505/tjtes.2015.49465.

Woo-Jin, Yi., & Tae Sung Kim (2017). Melatonin protects mice against stress-induced inflammation through enhancement of M2 macrophage polarization. Int. Immunopharmacol., 48, 146-158. DOI: 10.1016/j.intimp.2017.05.006.

Najafi, M., Shirazi, A., & Motevaseli, E. (2017). Melatonin as an anti-inflammatory agent in radiotherapy. Inflammopharmacol., 25 (4), 403-413. DOI: 10.1007/s10787-017-0332-5.

Peraçoli, J.C., Rudge, M.V.C., & Peraçoli, M.T. (2007). Tumor necrosis factor-alpha in gestation and puerperium of women with gestational hypertension and pre-eclampsia. Am. Journ. Reprod. Immunol., 57, 177-185. DOI: 10.1111/j.1600-0897.2006.00455.x.

Alijotas-Reig, J., Esteve-Valverde, E., Ferrer-Oliveras, R., Llurba, E., & Maria Gris J. (2017). Tumor necrosis factor-alpha and pregnancy: focus on biologics. An updated and comprehensive review. Clinic Rev. Allerg. Immunol., 53 (1), 40-53. DOI: 10.1007/s12016-016-8596-x.

Published

2018-11-16

Issue

Section

OBSTETRICS AND GYNECOLOGY

How to Cite

MELATONIN, PRO-INFLAMMATORY CYTOKINES AND PLACENTAL INSUFFICIENCY. (2018). Actual Problems of Pediatrics, Obstetrics and Gynecology, 2, 24-26. https://doi.org/10.11603/24116-4944.2018.2.8942